Healthcare Realty Trust (NYSE:HR) Rating Increased to Hold at StockNews.com

Healthcare Realty Trust (NYSE:HR) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold” rating in a report released on Wednesday.

Several other research firms have also recently weighed in on HR. Scotiabank reduced their target price on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a “sector perform” rating for the company in a research note on Tuesday, February 25th. Wells Fargo & Company cut their price target on Healthcare Realty Trust from $17.00 to $16.00 and set an “underweight” rating for the company in a report on Monday, March 10th. Finally, Wedbush decreased their price objective on Healthcare Realty Trust from $18.00 to $16.00 and set a “neutral” rating on the stock in a report on Monday, May 5th. One equities research analyst has rated the stock with a sell rating and five have given a hold rating to the company’s stock. According to MarketBeat, Healthcare Realty Trust has an average rating of “Hold” and an average price target of $17.00.

Healthcare Realty Trust Stock Down 0.9%

Shares of HR stock opened at $14.99 on Wednesday. Healthcare Realty Trust has a 12 month low of $14.45 and a 12 month high of $18.90. The firm has a market cap of $5.27 billion, a PE ratio of -8.42 and a beta of 0.92. The stock has a 50 day moving average of $15.80 and a 200-day moving average of $16.59.

Healthcare Realty Trust (NYSE:HR) last released its earnings results on Thursday, May 1st. The real estate investment trust reported $0.39 EPS for the quarter, meeting the consensus estimate of $0.39. Healthcare Realty Trust had a negative net margin of 51.60% and a negative return on equity of 11.20%. The firm had revenue of $288.86 million during the quarter, compared to analysts’ expectations of $297.39 million. During the same period in the prior year, the company earned $0.39 EPS. The business’s quarterly revenue was down 9.2% compared to the same quarter last year. As a group, equities analysts predict that Healthcare Realty Trust will post 1.59 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Thomas N. Bohjalian acquired 2,500 shares of the firm’s stock in a transaction on Tuesday, May 13th. The shares were purchased at an average cost of $14.71 per share, with a total value of $36,775.00. Following the completion of the purchase, the director now owns 56,502 shares of the company’s stock, valued at $831,144.42. This represents a 4.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.37% of the company’s stock.

Hedge Funds Weigh In On Healthcare Realty Trust

A number of large investors have recently modified their holdings of HR. Anchor Investment Management LLC acquired a new position in Healthcare Realty Trust in the first quarter valued at approximately $38,000. Bayforest Capital Ltd lifted its stake in shares of Healthcare Realty Trust by 262.0% in the 1st quarter. Bayforest Capital Ltd now owns 71,111 shares of the real estate investment trust’s stock valued at $1,202,000 after purchasing an additional 51,466 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Healthcare Realty Trust by 4.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,209,940 shares of the real estate investment trust’s stock valued at $37,348,000 after purchasing an additional 103,277 shares during the period. Empowered Funds LLC bought a new position in shares of Healthcare Realty Trust in the 1st quarter worth $202,000. Finally, Caxton Associates LLP acquired a new stake in shares of Healthcare Realty Trust during the first quarter worth $1,877,000.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.